CClinicalTrials.gg
Status unknownNCT04190719PaprikaUpdated Apr 30, 2021

Patient Empowerment for Major Surgery Preparation @ Home

An interventional study of multimodal prehabilitation in Urologic Diseases, Cardiovascular Diseases and Thoracic Diseases, sponsored by University Hospital, Grenoble. Status unknown at 1 site in France. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2021-04-30.

Sponsored by University Hospital, Grenoble · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Nov 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
225
Allocation
Non-randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Non-randomized monocentric open cohort study vs historical comparative group testing the efficacy of a multimodal prehabilitation program (based on physical activity, nutritional support and mental preparation) for unfit patients based on nutrition, physical activity and mental preparation in reducing postoperative complications in elective major surgery

Read the detailed description

Prehabilitation programs essentially based on physical activity improvement may reduce postoperative complications after major surgery. We hypothesize that a multimodal program based on physical activity, nutritional support and mental preparation may not only improve postoperative recovery and reduce costs but also improve health status beyond postoperative period.

Non-randomized monocentric open cohort study vs historical comparative group testing the efficacy of a multimodal prehabilitation program for unfit patients based on nutrition, physical activity and mental preparation in reducing postoperative complications in elective major surgery.

Other outcomes will be measured : length of hospital stay, hospital readmissions, direct costs, health status at 1 and 6 months.

Moreover, the feasibility and adherence of Paprika program will be evaluated. Inter-data centres relating to the implementation of the same prehabilitation program will be compared with the consortium Paprika (Hospital Clinic of Barcelona, University of Cologne, University of Gdansk)

02

Conditions studied

  • Urologic Diseases
  • Cardiovascular Diseases
  • Thoracic Diseases
  • Orthopedic Disorder
  • Gastrointestinal Disease
03

In context

Musculoskeletal Diseases

657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.

This study's planned enrollment of 225 is above the median of 73 across 438 interventional studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 816 studies on the registry; 206 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient eligible to elective major surgery (digestive, orthopedic, vascular-thoracic, urologic)
  • Age > 70 years and/or American Society of Anesthesiologists (ASA) score 3-4
  • or Unfit patient according to appropriate scores (Two among 3 scores (HAD, Physical activity score, nutritional score) below threshold). Unfit patients will be defined by at least 2 criteria if 'YES' answers: Physical activity: Less than 50% of WHO recommendations = less than 5000 steps/day or less than 75 min moderate activity/week or less than 12 min moderate activity/day Yes/No Malnutrition: BMI \< 20 kg/m2 if \< 70 years (or \<22 if >70y) = undernutrition Yes/No or BMI>25 kg/m2 (= overweight to obesity) or Loss of appetite? Mental evaluation HAD (Hospital Anxiety and Depression) >8 for A or D score Yes/No
  • Diagnosis:

Elective major surgery (digestive, orthopedic, vascular-thoracic, urologic)

  • Regulatory aspects: Be legally able to give consent Patient affiliated to social security

Exclusion criteria

Exclusion Criteria:

  • Planned surgery (less than 4 weeks at inclusion)
  • Urgent surgery
  • Patient with, at baseline, good to excellent physical, nutritional, mental status as defined by appropriate scores.
  • Patient considered not eligible to this program for physical or psychological reasons by the surgeon or the anesthetist
  • Persons referred in Articles L1121-5 to L1121-8 of the French code of public health (this corresponds to all persons protected: pregnant or parturient women, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons subject to a legal protection measure).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
225 participants (estimated)

Study arms

  • Experimental
    Paprika group

    Patients coming for elective major surgery will participate to Paprika program

    Other: multimodal prehabilitation

  • No intervention
    Historical group

    Patients previously operated with same characteristics

Interventions

  • Othermultimodal prehabilitation

    Paprika prehabilitation program content: patients will have choices for each activity. Messages and motivation will be reinforced by using a mobile app or leaflet advices, according to patient's preferences. * Physical activity promotion by discovering ebike, personalised gymnastics and encouragement to increase the number of daily steps of patients, measured by a wristband and a mobile App * An individualized nutritional optimization plan with dietary advices and protein supplementation (if necessary). * Psychological support will be proposed through auto-hypnosis sensibilisation or management of stress with Cognitive Behavior Stress Management technics

06

What researchers measure

Primary outcomes

  1. Rate of postoperative complications at Day-30

    Rate of postoperative complications at Day-30 classified following the standards of the European Society of Anaesthesiology and European Society of intensive Care Medicine.

    Time frame: at Day-30 post surgery

Secondary outcomes

  1. Number and severity of postoperative complications

    Number and severity of postoperative complications using Dindo-Clavien classification within 30 days

    Time frame: within 30 days post surgery

  2. Length of stay (ICU and Hospital)

    Length of ICU stay and Length of hospital stay

    Time frame: within 30 days post surgery

  3. Hospital readmission

    Hospital readmission within 30 days

    Time frame: within 30 days post surgery

  4. Direct cost

    Valuation in euros of the direct cost from a 1-month hospital point of view (duration and type of stay, acts, GHM...) by integrating for the intervention group the cost of the pre-habilitation program. Care consumption at 6 months from a social security perspective (Probabilistic Matching National Health Data System)--\> comparison of direct costs for the Prehab sessions (professional caregivers and materials costs) versus complication costs of control group

    Time frame: interventional group: 1 month-cost before surgery+1 month-post surgery / Control group: 1 month-cost post-surgery

  5. Physical activity health status

    Health status based on physical activity score:GPAQ and DASI scores

    Time frame: a baseline, presurgery and 6 months post surgery

  6. Nutritional health status

    Nutritional health status based on weight, appetite and ingesta measurements

    Time frame: at baseline, 1 month and 6 months

  7. Psychological health status

    Psychological health status based on HAD, Perceived Stress Scale scores

    Time frame: at baseline, 1 month and 6 months

  8. Number of patient participation to program in relation to the number of eligible patients

    Number of patient participation to program in relation to the number of eligible patients to assess faisability

    Time frame: During Paprika inclusion period

  9. Ratio patient participation to each session

    Ratio patient participation to each session to assess faisability and limitation to participation

    Time frame: During Paprika 1 month-sessions

  10. Comparison with other centers

    Comparison will be done with other cohorts using Paprika program (Barcelona, Gdansk and Köln) on common outcomes

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg. 2018 Jan;267(1):50-56. doi: 10.1097/SLA.0000000000002293. PubMed 28489682 ↗
  • Barberan-Garcia A, Ubre M, Pascual-Argente N, Risco R, Faner J, Balust J, Lacy AM, Puig-Junoy J, Roca J, Martinez-Palli G. Post-discharge impact and cost-consequence analysis of prehabilitation in high-risk patients undergoing major abdominal surgery: secondary results from a randomised controlled trial. Br J Anaesth. 2019 Oct;123(4):450-456. doi: 10.1016/j.bja.2019.05.032. Epub 2019 Jun 25. PubMed 31248644 ↗

Individual participant data

Plan to share: Yes — Anonymised data will be shared with Barcelona, Köln and Gdansk: all collected IPD

Supporting information: Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04190719
Lead sponsor
University Hospital, Grenoble
Collaborators
EIT Health, Hospital Clinic of Barcelona, Universitätsklinikum Köln, University Clinical Centre, Gdansk
Responsible party
Sponsor
First posted
Dec 9, 2019
Start date
Jan 3, 2020
Primary completion
Sep 30, 2021 (estimated)
Completion
Dec 31, 2021 (estimated)
Last update
Apr 30, 2021

Study contacts

Marie-France Vaillant
Contact
mfvaillant@chu-grenoble.fr
+33 4 76 76 89 13
Laura Albaladejo
Contact
EXT-LAlbaladejo@chu-grenoble.fr
Pierre Albaladejo, Prof.
principal investigator · CHU Grenoble Alpes

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion